Low Rate of Cetuximab Hypersensitivity Reactions in Northeast Tennessee: An Appalachian Effect?
Purpose: Cetuximab is a monoclonal antibody with a known risk of hypersensitivity reactions. Early studies showed hypersensitivity reaction rates of 3%, but there appears to be a higher incidence in the southeastern United States. To confirm the findings from nearby institutions that cetuximab-assoc...
| Main Authors: | , , , |
|---|---|
| Published: |
Digital Commons @ East Tennessee State University
2015
|
| Subjects: | |
| Online Access: | https://dc.etsu.edu/etsu-works/2323 https://doi.org/10.1177/1078155215618771 |